
Chief Executive Officer

Elaine has over 15 years of comprehensive experience in Early Phase clinical research, contributing to more than 250 clinical trial projects. With a strong strategic mindset, Elaine has demonstrated leadership experience with a proven ability to build strong rapport with collaborators and to strengthen partnerships. Over her career, Elaine has developed extensive knowledge in specialised clinical activities and deep understanding of various therapeutic areas.
A skills-based board combines comprehensive experience in academic research, financial strategy, commercial development and biotechnology & pharmaceutical industries. Along with the specialised leadership team, this expertise drives Doherty Clinical Trials Ltd unique capabilities.